Internal Medicine, Rheumatology · Norwich, CT
NPI
1205942836
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
12 Case St, 212
Norwich, CT, 06360
Phone (860) 859-9123
Groups this clinician bills Medicare through
Medicare paid, 2024
$419K
35,296 services
Medicare patients, 2024
581
Average age 73
Drug cost, 2024
$4.2M
5,733 prescriptions
Company payments, 2025
$2,424
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harjinder S Chowdhary was code J0897 (injection, denosumab, 1 mg), 1,380 times for 15 patients. In total Harjinder S Chowdhary billed 35,296 services in 33 codes, and Medicare paid $419K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 15 | $19.73 | $27K |
| 99214 Office E&M - Established | Office | 875 | 485 | $100.79 | $88K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 820 | 482 | $13.91 | $11K |
| 96413 Chemotherapy Administration | Office | 125 | 21 | $106.78 | $13K |
| 99213 Office E&M - Established | Office | 124 | 115 | $63.74 | $7,904 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 121 | 20 | $0.49 | $59.67 |
| 36415 Venipuncture Blood Collection | Office | 118 | 18 | $5.83 | $688 |
| 99204 Office E&M - New | Office | 62 | 62 | $136.42 | $8,458 |
| 96365 Intravenous Infusion, Hydration | Office | 45 | 15 | $55.59 | $2,501 |
| 96401 Chemotherapy Administration | Office | 44 | 13 | $60.81 | $2,676 |
| 96372 Injection Administration | Office | 19 | 14 | $12.94 | $246 |
| 99442 Telephone Services | Office | 11 | 11 | $63.31 | $696 |
By year: 2022 $445K for 28,884 services; 2023 $446K for 33,371 services; 2024 $419K for 35,296 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 118 | 18 | $5.83 | $688 |
Medicare prescription drug claims, 2024
In 2024, the drug Harjinder S Chowdhary prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,272 prescriptions and refills. In total Harjinder S Chowdhary wrote 5,733 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,272 | 2,775 | 317 | $29K |
| Prednisone Generic | 810 | 1,194 | 222 | $4,735 |
| Methotrexate Methotrexate Sodium | 664 | 1,473 | 156 | $13K |
| Gabapentin Generic | 449 | 833 | 104 | $5,168 |
| Alendronate Sodium Generic | 301 | 661 | 99 | $4,302 |
| Duloxetine Hcl Generic | 246 | 518 | 56 | $5,302 |
| Allopurinol Generic | 233 | 562 | 61 | $2,716 |
| Celecoxib Generic | 167 | 283 | 38 | $3,446 |
| Meloxicam Generic | 141 | 269 | 50 | $572 |
| Folic Acid Generic | 95 | 241 | 29 | $640 |
| Orencia Clickject Abatacept | 93 | 115 | 13 | $654K |
| Enbrel Sureclick Etanercept | 92 | 108 | 14 | $772K |
| Otezla Apremilast | 78 | 86 | Under 11 | $389K |
| Pilocarpine Hcl Generic | 54 | 87 | 12 | $2,675 |
| Colchicine Generic | 52 | 94 | 29 | $1,647 |
Brand drugs: 675 claims; generic drugs: 5,043 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harjinder S Chowdhary $2,424 ($2,424 in general payments such as food, travel and fees) from 24 companies. The largest payer was Amgen Inc. with $395.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $395 |
| Mallinckrodt Hospital Products Inc. | 14 | $308 |
| Abbvie Inc. ABBV | 16 | $271 |
| Janssen Biotech, Inc. JNJ | 12 | $266 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $171 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $145 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $103 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $92.71 |
| Pfizer Inc. PFE | 4 | $82.83 |
| UCB, Inc. UCB.BR | 3 | $81.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.